Cell proliferation is a method which calculates rise in the number of cells and is defined by the balance between cell loss and cell divisions. A cell proliferation kit or assay offers a thorough count of cell proliferation (determining the number of dividing cells) and viability (determining the number of healthy cells). Apart from the cell proliferation quantification regarding nutrients, mitogens, etc.; it is also used in the detection and analysis of pharmaceutical compounds and toxic agents. Wide usage of toxicology testing in the food and beverages sector is the key factor driving the demand for cell proliferation kits. These kits find application mainly in pharmaceutical companies and biotechnology firms and research labs and academic institutes.
In-Depth research report on Cell Proliferation Kits Market :
https://www.radiantinsights.com/research/global-cell-proliferation-kits-market-2018-2022
Pharma Companies to be the Largest Application Segment
Pharmaceutical companies and biotech firms dominated the overall application segment in the past and accounted for the largest share. The segment is expected to maintain its growth even during the forecast years i.e., from 2018 to 2022. Wide usage of these kits by these companies for screening of vaccines and drugs is the key factor behind the dominance of this segment. Manufacturers in this field focus on new product development for business development.
One such recent activity includes the launch of VICTOR Nivo Multimode Plate Reader by PerkinElmer. Officials at the company said that pharma companies, labs and academic firms need high performing advanced devices capable of being used in a variety of applications. Several detection modes coupled with improved software can expedite testing of quantification of protein/DNA, cell proliferation, measuring cytotoxicity, etc.
Market Overview
The findings of a research report available on Radiant Insights, Inc. suggests that the global cell proliferation kits market would witness a considerable demand over the coming years. The report also says that the market would expand at a growth rate of 7.75 % from 2018 to 2022. Increased need for high throughput chemical toxicology assessment for food safety is expected to spur the market growth. Several other factors encouraging market growth are rising awareness regarding the consumption of nutritional products and increased demand for cytotoxic drugs. Key companies in the cell proliferation kits market include Thermo Fisher Scientific; F. Bio-Rad Laboratories, Inc.; General Electric; and Merck & Company, Inc.
Pharma Companies to be the Largest Application Segment
Pharmaceutical companies and biotech firms dominated the overall application segment in the past and accounted for the largest share. The segment is expected to maintain its growth even during the forecast years i.e., from 2018 to 2022. Wide usage of these kits by these companies for screening of vaccines and drugs is the key factor behind the dominance of this segment. Manufacturers in this field focus on new product development for business development.
One such recent activity includes the launch of VICTOR Nivo Multimode Plate Reader by PerkinElmer. Officials at the company said that pharma companies, labs and academic firms need high performing advanced devices capable of being used in a variety of applications. Several detection modes coupled with improved software can expedite testing of quantification of protein/DNA, cell proliferation, measuring cytotoxicity, etc.
Market Overview
The findings of a research report available on Radiant Insights, Inc. suggests that the global cell proliferation kits market would witness a considerable demand over the coming years. The report also says that the market would expand at a growth rate of 7.75 % from 2018 to 2022. Increased need for high throughput chemical toxicology assessment for food safety is expected to spur the market growth. Several other factors encouraging market growth are rising awareness regarding the consumption of nutritional products and increased demand for cytotoxic drugs. Key companies in the cell proliferation kits market include Thermo Fisher Scientific; F. Bio-Rad Laboratories, Inc.; General Electric; and Merck & Company, Inc.
Free request sample :
No comments:
Post a Comment